ExploreWatchlistsPricing
  1. JP-listed companies
  2. kainos loboratories,inc
  3. Financials
  4. Total assets

kainos loboratories,inc (4556)

Market cap
¥10.4B
P/E ratio
16x
Kainos manufactures diagnostic pharmaceuticals, laboratory reagents, and medical devices for hospitals and research facilities to improve healthcare quality.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal assets (Million JPY)YoY (%)
Mar 31, 20269,567+8.90%
Mar 31, 20258,785+2.26%
Mar 31, 20248,591+5.85%
Mar 31, 20238,116+7.19%
Mar 31, 20227,572+8.75%
Mar 31, 20216,962+3.23%
Mar 31, 20206,745+15.12%
Mar 31, 20195,859-4.66%
Mar 31, 20186,145+5.89%
Mar 31, 20175,803-1.78%
Mar 31, 20165,909-4.95%
Mar 31, 20156,216

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat